Surgery Partners (SGRY) had its price target lowered by TD Cowen from $28.00 to $20.00. They now have a "buy" rating on the stock.
Surgery Partners (SGRY) had its price target lowered by UBS Group AG from $29.00 to $21.00. They now have a "buy" rating on the stock.
Surgery Partners (SGRY) had its price target lowered by Mizuho from $19.00 to $17.00. They now have an "outperform" rating on the stock.
Has Surgery Partners (SGRY) Slump Opened A New Opportunity For Investors? [Yahoo! Finance]
ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS [Yahoo! Finance]